PET-CT Scanners

Global PET-CT Scanners Market to Reach US$2.3 Billion by 2030

The global market for PET-CT Scanners estimated at US$1.7 Billion in the year 2024, is expected to reach US$2.3 Billion by 2030, growing at a CAGR of 5.0% over the analysis period 2024-2030. Stationary, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$1.6 Billion by the end of the analysis period. Growth in the Portable / Mobile segment is estimated at 5.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$455.2 Million While China is Forecast to Grow at 8.3% CAGR

The PET-CT Scanners market in the U.S. is estimated at US$455.2 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$490.7 Million by the year 2030 trailing a CAGR of 8.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.5% and 4.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.2% CAGR.

Global PET-CT Scanners Market - Key Trends and Drivers Summarized

Unveiling the Intricacies of PET-CT Scanners: A Modern Medical Marvel

PET-CT scanners represent a pinnacle in medical imaging technology, combining the capabilities of Positron Emission Tomography (PET) and Computed Tomography (CT) to provide comprehensive diagnostic images. PET scans detect metabolic activity by tracing a radioactive tracer injected into the patient, highlighting areas of abnormal metabolic function which are often indicative of disease. CT scans, on the other hand, use X-rays to produce detailed cross-sectional images of the body’s internal structures. When combined, PET-CT scanners offer unparalleled diagnostic accuracy, allowing for precise localization of metabolic abnormalities within the anatomical context provided by CT images. This synergy is particularly valuable in oncology, where it aids in tumor detection, staging, and monitoring treatment response.

How Are Technological Advances Enhancing PET-CT Imaging?

Technological advancements have significantly enhanced the capabilities and accuracy of PET-CT scanners. One notable innovation is the development of digital PET detectors, which provide higher resolution images and improved sensitivity compared to traditional analog detectors. This advancement allows for earlier detection of smaller lesions and more accurate quantification of tracer uptake. Additionally, time-of-flight (TOF) technology has been integrated into PET-CT systems, reducing image noise and improving lesion detectability. Another major improvement is the incorporation of artificial intelligence (AI) and machine learning algorithms, which assist in image reconstruction, noise reduction, and automated interpretation, leading to faster and more accurate diagnoses. Moreover, advances in radiotracer development have expanded the range of detectable biological processes, enabling more precise characterization of various diseases beyond cancer, such as neurological and cardiovascular disorders.

What Role Does PET-CT Play in Personalized Medicine?

The role of PET-CT scanners in personalized medicine is growing, as they provide critical information that guides tailored treatment strategies. In oncology, PET-CT imaging is instrumental in identifying the molecular characteristics of tumors, enabling clinicians to select the most effective therapies based on the specific metabolic activity of the cancer. This approach enhances the efficacy of treatments and minimizes unnecessary interventions. Furthermore, PET-CT is increasingly used in the assessment of neurological conditions, such as Alzheimer’s disease, by detecting early metabolic changes in the brain. This early detection capability is crucial for implementing timely interventions that can slow disease progression. In cardiology, PET-CT aids in assessing myocardial viability and perfusion, guiding decisions regarding revascularization procedures. The ability to integrate metabolic and anatomical information in a single imaging session makes PET-CT an invaluable tool in the move towards more precise and individualized patient care.

What Factors Are Driving Growth in the PET-CT Scanner Market?

The growth in the PET-CT scanner market is driven by several factors. Firstly, the increasing prevalence of cancer and other chronic diseases worldwide is fueling the demand for advanced diagnostic imaging technologies that can provide accurate and early detection. Secondly, continuous technological innovations, such as the development of digital detectors and AI-enhanced imaging, are improving the performance and efficiency of PET-CT scanners, making them more attractive to healthcare providers. Additionally, the expansion of applications beyond oncology into neurology and cardiology is broadening the market scope. Government initiatives and funding aimed at improving diagnostic capabilities and healthcare infrastructure are also playing a significant role in market expansion. Moreover, the growing adoption of personalized medicine is boosting the need for precise diagnostic tools like PET-CT scanners, which support individualized treatment planning. Lastly, increased investment in healthcare by emerging economies is creating new opportunities for market growth, as these regions upgrade their medical imaging infrastructure to meet rising healthcare demands.

SCOPE OF STUDY:

The report analyzes the PET-CT Scanners market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Installation (Stationary, Portable / Mobile); Type (Full Ring, Partial Ring); Application (Oncology, Cardiology, Neurology, Other Applications); End-Use (Hospitals, Diagnostic Centers, Other End-Uses)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

• BC Technical, Inc.
• Brain Biosciences, Inc.
• Capintec, Inc.
• CMR Naviscan Corporation
• Cubresa Inc.
• FUJIFILM Holdings Corporation
• GE Healthcare
• Mediso Ltd.
• Mediso Medical Imaging Systems
• Orbit Medical Technologies, Inc.
• Oxford Instruments Healthcare
• Philips Healthcare
• Positron Corporation
• Roses Medical & Surgical Supply
• Sanders Medical Products, Inc.
• Siemens Healthineers
• Sophie Biosciences Inc
• Toshiba Medical Systems Corporation

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.